Does K71.0 require prior authorization?

No, K71.0 does not require prior authorization (high confidence). Covered without prior authorization.

`K71.0`, Toxic liver disease with cholestasis

ICD-10-CM

No Prior Auth Required

Covered without prior authorization (high confidence)

This billing and coding article provides guidelines that complement Local Coverage Determination L34415 for CT of the abdomen and pelvis; consult LCD L34415 for specific coverage indications, limitations, and documentation requirements.
This article provides billing, coding, and guideline information that complements Local Coverage Determination (LCD) L34544; consult LCD L34544 for clinical eligibility, coverage criteria, and required documentation for hospice services for liver disease.
Documented clinical indication for MRCP (e.g., symptoms such as obstructive jaundice, cholangitis, biliary-type abdominal pain, pancreatitis).
Pre-test probability and relevant clinical context (e.g., suspected choledocholithiasis, cholestatic liver enzyme pattern, prior imaging findings).

Adjunctive imaging in suspected autoimmune pancreatitis (AIP) to evaluate main pancreatic duct narrowing, MPD integrity (secretin-MRCP may demonstrate duct-penetrating sign), and parenchymal features (but MRCP cannot fully replace ERCP in AIP diagnostic workup).
Imaging of biliary tree to help plan directed interventions (endoscopic or transhepatic) in complex biliary disease where MRCP may increase likelihood of success and decrease risk.
Preoperative evaluation of the common bile duct prior to laparoscopic cholecystectomy in persons with elevations of their transaminases or common bile duct dilatation on abdominal imaging (ultrasound or CT scan).
Non-invasive imaging to demonstrate biliary calculi and pancreatic ductal disease (general role of MRCP in biliary/pancreatic evaluation).
Diagnosis of choledocholithiasis/common bile duct (CBD) stones in patients suspected of having CBD stones (used as a first-line or noninvasive diagnostic test in appropriate clinical settings).
As an alternative to diagnostic ERCP when therapeutic intervention is not anticipated and a noninvasive study is preferred to avoid ERCP complications.

AETNA-CPB-0384, Magnetic Resonance Cholangiopancreatography

A56421, Billing and Coding: CT of the Abdomen and Pelvis

A56669, Billing and Coding: Hospice - Liver Disease

Ask Backwork about documentation requirements, denial risks, or coverage in your state.